Please login to the form below

Not currently logged in
Email:
Password:

mouth cancer

This page shows the latest mouth cancer news and features for those working in and with pharma, biotech and healthcare.

NICE set to reject Merck’s Erbitux for head and neck cancer

NICE set to reject Merck’s Erbitux for head and neck cancer

Merck has since provided further evidence for Erbitux to assist this appraisal process, reducing the indication to patients with mouth cancer alone as well as proposing an additional, undisclosed discount. ... However, the committee said that the new

Latest news

  • UK's Change4Life health programme launches drinks tracker app UK's Change4Life health programme launches drinks tracker app

    Aside from the link with liver disease and pancreatitis, regular consumption of two large glasses of wine or two pints of strong lager a day could increase the occurrence of mouth ... cancer three-fold.

  • PR and Med Ed news in brief

    Dental campaign success. Mouth Cancer Awareness Week 2004 was the most successful mouth cancer campaign ever said the British Dental Health Foundation.

  • Ethnic Minority Cancer Awareness Week

    Sir Trevor McDonald is backing a campaign to raise levels of awareness about the affects of cancer on Black and Minority Ethnic (BME) communities. ... of mouth cancer and Bangladeshi and Chinese communities having a higher incidence of liver cancer.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics